» Articles » PMID: 30307708

Right Heart Failure As a Risk Factor for Severe Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: Prospective Cohort Study

Abstract

Background: The prognosis in patients with Chronic Obstructive Pulmonary Disease (COPD) depends, in large part, on the frequency of exacerbations. Cardiovascular diseases, including heart failure (HF), are the risk factors for exacerbations. However, the importance of HF type over the exacerbations in COPD patients is unknown.

Objective: To determine whether right heart failure (RHF) is an independent risk factor for severe exacerbations in patients with COPD.

Methods: A prospective cohort study of 133 patients diagnosed with COPD with a follow-up period from 2010 to 2016. Patients with bronchial hyperreactivity, asthma, or pulmonary embolism were excluded.

Results: The mean age was 74.7 ± 8.2 years and 43.6% were men, 69.9% had severe exacerbations during follow-up. Subjects with RHF had lower FEV (50.2 ± 19.9 vs 57.4 ± 16.9, P = .006) and greater incidence of stroke (15.4% vs 1.8%, P = .009) compared to those without RHF. Subjects with RHF were at higher risk of severe exacerbations (HR, 2.46; CI 95%, 1.32-4.58, P = .005) compared to those without RHF after adjusting for confounding variables.

Conclusion: In patients with COPD, RHF is an independent risk factor for suffering severe exacerbations.

Citing Articles

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.

Hurst J, Han M, Singh B, Sharma S, Kaur G, De Nigris E Respir Res. 2022; 23(1):213.

PMID: 35999538 PMC: 9396841. DOI: 10.1186/s12931-022-02123-5.


Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.

Mullerova H, Marshall J, De Nigris E, Varghese P, Pooley N, Embleton N Ther Adv Respir Dis. 2022; 16:17534666221113647.

PMID: 35894441 PMC: 9340406. DOI: 10.1177/17534666221113647.


Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.

Vera-Zertuche J, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, Aguirre-Garcia M, Segura-Badilla O Epidemiol Infect. 2021; 149:e109.

PMID: 33913410 PMC: 8134888. DOI: 10.1017/S0950268821001023.


Serum bilirubin level is associated with exercise capacity and quality of life in chronic obstructive pulmonary disease.

Leem A, Kim Y, Lee J, Kim T, Kim H, Oh Y Respir Res. 2019; 20(1):279.

PMID: 31818285 PMC: 6902503. DOI: 10.1186/s12931-019-1241-5.